2025-01-012025-12-312025-12-31false03658624Ridgeland Associates Limited2026-05-29falseiso4217:GBPxbrli:pure036586242024-12-31036586242025-12-31036586242025-01-012025-12-31036586242023-12-31036586242024-12-31036586242024-01-012024-12-3103658624bus:SmallEntities2025-01-012025-12-3103658624bus:AuditExempt-NoAccountantsReport2025-01-012025-12-3103658624bus:FullAccounts2025-01-012025-12-3103658624bus:PrivateLimitedCompanyLtd2025-01-012025-12-3103658624core:WithinOneYear2025-12-3103658624core:AfterOneYear2025-12-3103658624core:WithinOneYear2024-12-3103658624core:AfterOneYear2024-12-3103658624core:ShareCapital2025-12-3103658624core:SharePremium2025-12-3103658624core:RevaluationReserve2025-12-3103658624core:OtherReservesSubtotal2025-12-3103658624core:RetainedEarningsAccumulatedLosses2025-12-3103658624core:ShareCapital2024-12-3103658624core:SharePremium2024-12-3103658624core:RevaluationReserve2024-12-3103658624core:OtherReservesSubtotal2024-12-3103658624core:RetainedEarningsAccumulatedLosses2024-12-3103658624core:LandBuildings2025-12-3103658624core:PlantMachinery2025-12-3103658624core:Vehicles2025-12-3103658624core:FurnitureFittings2025-12-3103658624core:OfficeEquipment2025-12-3103658624core:NetGoodwill2025-12-3103658624core:IntangibleAssetsOtherThanGoodwill2025-12-3103658624core:ListedExchangeTraded2025-12-3103658624core:UnlistedNon-exchangeTraded2025-12-3103658624core:LandBuildings2024-12-3103658624core:PlantMachinery2024-12-3103658624core:Vehicles2024-12-3103658624core:FurnitureFittings2024-12-3103658624core:OfficeEquipment2024-12-3103658624core:NetGoodwill2024-12-3103658624core:IntangibleAssetsOtherThanGoodwill2024-12-3103658624core:ListedExchangeTraded2024-12-3103658624core:UnlistedNon-exchangeTraded2024-12-3103658624core:LandBuildings2025-01-012025-12-3103658624core:PlantMachinery2025-01-012025-12-3103658624core:Vehicles2025-01-012025-12-3103658624core:FurnitureFittings2025-01-012025-12-3103658624core:OfficeEquipment2025-01-012025-12-3103658624core:NetGoodwill2025-01-012025-12-3103658624core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3103658624core:ListedExchangeTraded2025-01-012025-12-3103658624core:UnlistedNon-exchangeTraded2025-01-012025-12-3103658624core:MoreThanFiveYears2025-01-012025-12-3103658624core:Non-currentFinancialInstruments2025-12-3103658624core:Non-currentFinancialInstruments2024-12-3103658624dpl:CostSales2025-01-012025-12-3103658624dpl:DistributionCosts2025-01-012025-12-3103658624core:LandBuildings2025-01-012025-12-3103658624core:PlantMachinery2025-01-012025-12-3103658624core:Vehicles2025-01-012025-12-3103658624core:FurnitureFittings2025-01-012025-12-3103658624core:OfficeEquipment2025-01-012025-12-3103658624dpl:AdministrativeExpenses2025-01-012025-12-3103658624core:NetGoodwill2025-01-012025-12-3103658624core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3103658624dpl:GroupUndertakings2025-01-012025-12-3103658624dpl:ParticipatingInterests2025-01-012025-12-3103658624dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012025-12-3103658624core:ListedExchangeTraded2025-01-012025-12-3103658624dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012025-12-3103658624core:UnlistedNon-exchangeTraded2025-01-012025-12-3103658624dpl:CostSales2024-01-012024-12-3103658624dpl:DistributionCosts2024-01-012024-12-3103658624core:LandBuildings2024-01-012024-12-3103658624core:PlantMachinery2024-01-012024-12-3103658624core:Vehicles2024-01-012024-12-3103658624core:FurnitureFittings2024-01-012024-12-3103658624core:OfficeEquipment2024-01-012024-12-3103658624dpl:AdministrativeExpenses2024-01-012024-12-3103658624core:NetGoodwill2024-01-012024-12-3103658624core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3103658624dpl:GroupUndertakings2024-01-012024-12-3103658624dpl:ParticipatingInterests2024-01-012024-12-3103658624dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3103658624core:ListedExchangeTraded2024-01-012024-12-3103658624dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3103658624core:UnlistedNon-exchangeTraded2024-01-012024-12-3103658624core:NetGoodwill2025-12-3103658624core:IntangibleAssetsOtherThanGoodwill2025-12-3103658624core:LandBuildings2025-12-3103658624core:PlantMachinery2025-12-3103658624core:Vehicles2025-12-3103658624core:FurnitureFittings2025-12-3103658624core:OfficeEquipment2025-12-3103658624core:AfterOneYear2025-12-3103658624core:WithinOneYear2025-12-3103658624core:ListedExchangeTraded2025-12-3103658624core:UnlistedNon-exchangeTraded2025-12-3103658624core:ShareCapital2025-12-3103658624core:SharePremium2025-12-3103658624core:RevaluationReserve2025-12-3103658624core:OtherReservesSubtotal2025-12-3103658624core:RetainedEarningsAccumulatedLosses2025-12-3103658624core:NetGoodwill2024-12-3103658624core:IntangibleAssetsOtherThanGoodwill2024-12-3103658624core:LandBuildings2024-12-3103658624core:PlantMachinery2024-12-3103658624core:Vehicles2024-12-3103658624core:FurnitureFittings2024-12-3103658624core:OfficeEquipment2024-12-3103658624core:AfterOneYear2024-12-3103658624core:WithinOneYear2024-12-3103658624core:ListedExchangeTraded2024-12-3103658624core:UnlistedNon-exchangeTraded2024-12-3103658624core:ShareCapital2024-12-3103658624core:SharePremium2024-12-3103658624core:RevaluationReserve2024-12-3103658624core:OtherReservesSubtotal2024-12-3103658624core:RetainedEarningsAccumulatedLosses2024-12-3103658624core:NetGoodwill2023-12-3103658624core:IntangibleAssetsOtherThanGoodwill2023-12-3103658624core:LandBuildings2023-12-3103658624core:PlantMachinery2023-12-3103658624core:Vehicles2023-12-3103658624core:FurnitureFittings2023-12-3103658624core:OfficeEquipment2023-12-3103658624core:AfterOneYear2023-12-3103658624core:WithinOneYear2023-12-3103658624core:ListedExchangeTraded2023-12-3103658624core:UnlistedNon-exchangeTraded2023-12-3103658624core:ShareCapital2023-12-3103658624core:SharePremium2023-12-3103658624core:RevaluationReserve2023-12-3103658624core:OtherReservesSubtotal2023-12-3103658624core:RetainedEarningsAccumulatedLosses2023-12-3103658624core:AfterOneYear2025-01-012025-12-3103658624core:WithinOneYear2025-01-012025-12-3103658624core:Non-currentFinancialInstrumentscore:CostValuation2025-01-012025-12-3103658624core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-012025-12-3103658624core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-012025-12-3103658624core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-012025-12-3103658624core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-012025-12-3103658624core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-012025-12-3103658624core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3103658624core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3103658624core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3103658624core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3103658624core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3103658624core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3103658624core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3103658624core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3103658624core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3103658624core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3103658624core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3103658624core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3103658624core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3103658624core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3103658624core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3103658624core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3103658624core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3103658624core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3103658624core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3103658624core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3103658624core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3103658624bus:Director12025-01-012025-12-31

Ridgeland Associates Limited

Registered Number
03658624
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

Ridgeland Associates Limited
Company Information
for the year from 1 January 2025 to 31 December 2025

Director

R Gunson

Registered Address

18 Shere Avenue
Cheam
Sutton
SM2 7JU

Registered Number

03658624 (England and Wales)
Ridgeland Associates Limited
Balance Sheet as at
31 December 2025

Notes

2025

2024

£

£

£

£

Current assets
Stocks324,0979,460
Debtors44,4599,911
Current asset investments5632-
Cash at bank and on hand24,67840,919
53,86660,290
Creditors amounts falling due within one year6(34,719)(37,618)
Net current assets (liabilities)19,14722,672
Total assets less current liabilities19,14722,672
Creditors amounts falling due after one year7(12,000)(24,000)
Net assets7,147(1,328)
Capital and reserves
Called up share capital33
Profit and loss account7,144(1,331)
Shareholders' funds7,147(1,328)
The financial statements were approved and authorised for issue by the Director on 29 May 2026, and are signed on its behalf by:
R Gunson
Director
Registered Company No. 03658624
Ridgeland Associates Limited
Notes to the Financial Statements
for the year ended 31 December 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the director has reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore, continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Investments
Current asset investments comprise listed equity investments held for resale and treasury management purposes. Investments are initially recognised at cost and are subsequently measured at fair value at the reporting date, with movements in fair value recognised in profit or loss. Gains and losses arising on the disposal of investments, together with unrealised holding gains and losses arising from changes in fair value at the year end, are recognised within the profit and loss account in the period in which they arise. Listed investments are valued using quoted market prices at the balance sheet date.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
2.Average number of employees

20252024
Average number of employees during the year11
3.Stocks

2025

2024

££
Finished goods24,0979,460
Total24,0979,460
4.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables-259
Amounts owed by associates and joint ventures / participating interests-3,341
Other debtors3,0426,311
Prepayments and accrued income1,417-
Total4,4599,911
5.Current asset investments
The value of investments in equity funds at the balance sheet date was £632 (2024 -nil). Gains and losses arising on the disposal of investments, together with unrealised holding gains and losses arising from changes in fair value at the year end, are recognised within the profit and loss account in the period in which they arise. Listed investments are valued using quoted market prices at the balance sheet date.
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables31,86032,444
Bank borrowings and overdrafts-497
Amounts owed to related parties344-
Taxation and social security3902,646
Accrued liabilities and deferred income2,1252,031
Total34,71937,618
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
7.Creditors: amounts due after one year

2025

2024

££
Trade creditors / trade payables12,00024,000
Total12,00024,000